open access

Vol 10, Supp. C (2014)
Case report
Published online: 2014-08-29
Get Citation

Complete response during treatment with abiraterone in castration-resistant prostate cancer — case report

Joanna Hudała-Klecha, Barbara Radecka

open access

Vol 10, Supp. C (2014)
CASE REPORT
Published online: 2014-08-29

Abstract

Prostatic cancer is one of the most common male cancer. Systemic treatment of metastatic castrate-resistant prostate cancer (mCRPC) after progression on docetaxel chemotherapy may prolongs overall survival. We describe a case of complete response during treatment with abiraterone in castration resistant prostate cancer.

Abstract

Prostatic cancer is one of the most common male cancer. Systemic treatment of metastatic castrate-resistant prostate cancer (mCRPC) after progression on docetaxel chemotherapy may prolongs overall survival. We describe a case of complete response during treatment with abiraterone in castration resistant prostate cancer.

Get Citation

Keywords

castrate-resistant prostate cancer, abirateron

About this article
Title

Complete response during treatment with abiraterone in castration-resistant prostate cancer — case report

Journal

Oncology in Clinical Practice

Issue

Vol 10, Supp. C (2014)

Article type

Case report

Pages

6-8

Published online

2014-08-29

Keywords

castrate-resistant prostate cancer
abirateron

Authors

Joanna Hudała-Klecha
Barbara Radecka

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl